Aurinia Pharmaceuticals Inc (AUPH) Stock Price, Quote & AI Analysis
Live AUPH stock price, real-time charts, AI-powered analysis, technical analysis, earnings insights, and market sentiment for Aurinia Pharmaceuticals Inc.
TradeVae provides AI-driven analysis and real-time market intelligence for Aurinia Pharmaceuticals Inc (AUPH), including price action, technical indicators, earnings performance, analyst sentiment, and risk-aware market context.
AI Analysis
Explore comprehensive AI-powered analysis including summary insights, bull and bear cases, key risks, and factors to watch.
Generating AI analysis...
Aurinia Pharmaceuticals Inc's fundamentals reflect its scale, profitability, and position within the global technology sector. Key valuation and financial metrics are summarized below, followed by detailed financial statements.
Aurinia Pharmaceuticals Inc Overview
Company information
Company Overview
Aurinia Pharmaceuticals, Inc. is a clinical stage bio-pharmaceutical company, which engages in the research, development, and commercialization of therapeutic drugs. The company was founded by Robert Foster, Richard Glickman, and Michael Martin on June 16, 1993 and is headquartered in Edmonton, Canada.
Company Details
Technical Indicators
Key technical analysis metrics and indicators
Loading technical indicators...
Valuation Metrics
Key valuation ratios and comparisons
Loading valuation metrics...
Aurinia Pharmaceuticals Inc Earnings & Financial Statements
Earnings Calendar
Upcoming earnings dates and historical surprises
Loading earnings calendar...
Financial Statements
Income statements, balance sheets, and cash flow
Loading income statements...
Loading balance sheets...
Loading cash flow statements...